![Sheraz Mian Sheraz Mian](https://staticx.zacks.com/images/mugshots/sheraz_mian/sheraz_mian-4.png)
Top Analyst Reports for Amazon.com, Roche & GE Aerospace
![](https://staticx.zacks.com/images/zt/ztNow_icon2.png)
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Friday, September 6, 2024
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Roche Holding AG (RHHBY) and GE Aerospace (GE), as well as two micro-cap stocks Canterbury Park Holding Corporation (CPHC) and NVE Corporation (NVEC). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.
These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Amazon.com shares have lost ground lately, along with the rest of its Magnificent 7 peers and other megacap Tech operators, but they have still been strong performers this year (up +13.7% vs. +15.3% for the S&P 500 index. The company is gaining on solid Prime momentum owing to ultrafast delivery services and strong content portfolio. Strengthening relationship with third-party sellers is a positive.
Amazon.com’s expanding global presence and solid momentum among the small and medium businesses, remain a plus. Growing adoption of AWS is aiding Amazon’s cloud dominance. Deepening focus on generative AI is a major plus. Also, improving Alexa skills along with robust smart home products offerings are tailwinds. Growing capabilities in grocery, pharmacy, healthcare and autonomous driving are other positives.
However, macroeconomic challenges remain headwinds. Amazon issued weak third-quarter 2024 revenue guidance due to the changing shopping pattern of consumers, which is a negative.
(You can read the full research report on Amazon.com here >>>)
Shares of Roche have outperformed the Zacks Large Cap Pharmaceuticals industry over the past three months (+22.0% vs. +4.1%). Th company’s performance in the second quarter and the first half of 2024 was impressive because of the high demand for its drugs and tests.
The second quarter saw an acceleration in growth as total sales were no longer affected by the decline in COVID-19 sales, resulting in very strong sales growth. Consequently, Roche raised its earnings outlook for the full year. Vabysmo, Ocrevus, Evrysdi and Polivy boost growth. Vabysmo has put up a stellar performance against Eylea.
Meanwhile, Roche is also looking to diversify and make inroads in the lucrative obesity market in the wake of declining sales from legacy drugs due to competition from biosimilars. The company’s efforts to develop new drugs are encouraging. The base diagnostics business is also performing well.
(You can read the full research report on Roche here >>>)
Shares of GE Aerospace have outperformed the Zacks Transportation - Airline industry over the past six months (+25.1% vs. +7.7%). The company has been witnessing strength in its businesses, driven by robust demand for commercial engines, propulsion and additive technologies.
Rising U.S. & international defense budgets, geopolitical tensions, positive airline & airframer dynamics and robust demand for commercial air travel augur well for the company. GE Aerospace remains committed to making investments to boost growth and provide better services to its customers.
Its portfolio-reshaping actions are likely to unlock values for its shareholders. Its shareholder-friendly policies are encouraging. For 2024, it expects organic revenues to grow in the high-single-digit range from the year-ago level. However, it has been dealing with high costs and expenses related to projects and restructuring activities.
(You can read the full research report on GE here >>>)
Canterbury Park’s shares have underperformed the Zacks Gaming industry over the year-to-date period (-0.6% vs. +6.8%). This microcap company with market capitalization of $100.78 million offers significant long-term revenue potential through diversified projects like an amphitheater, Winners Circle and residential units, driving growth beyond traditional gaming.
Financially stable with $24 million in cash and short-term investments, Canterbury Park can fund growth without debt. Improved EBITDA margins and diversified revenue streams, including pari-mutuel wagering and event hosting, support CPHC’s earnings stability. The company’s vision of a regional destination is progressing, with leasing success indicating solid demand.
However, risks include a 93.6% drop in second-quarter 2024 net income due to a non-recurring gain in 2023, weak casino revenues and substantial losses from equity investments. Increased competition from nearby casinos could impact market share and profitability.
(You can read the full research report on Canterbury Park here >>>)
Shares of NVE have gained +0.5% over the year-to-date period against the Zacks Electronics - Semiconductors industry’s gain of +16.2%. This microcap company with market capitalization of $367.89 million exhibits strong margins in the fiscal first quarter of 2025, with gross margin rising to 86% and operating margin at 65%, driven by a profitable product mix and direct sales.
The company's increased R&D spending by 26%, especially in wafer-level chip scale packaging aimed at medical and industrial applications, expected to drive new revenue streams. Despite a 24% sales decline due to semiconductor downturns, strong cash flows and a $53 million cash reserve support a steady $1.00 per share dividend. NVE Corporation's focus on spintronic technologies positions it well in high-growth sectors.
However, revenue risks persist with heavy reliance on key customers and competitive pressures. Rising operating expenses and labor market challenges may pressure near-term profitability, while supply-chain vulnerabilities and inventory management issues could impact operational efficiency.
(You can read the full research report on NVE here >>>)
Other noteworthy reports we are featuring today include IQVIA Holdings Inc. (IQV), Discover Financial Services (DFS) and Cenovus Energy Inc. (CVE).
Director of Research
Sheraz Mian
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Get the latest research report on AMZN - FREE
Get the latest research report on GE - FREE
Get the latest research report on RHHBY - FREE
Get the latest research report on DFS - FREE
Get the latest research report on CVE - FREE
Get the latest research report on NVEC - FREE
Get the latest research report on IQV - FREE
Get the latest research report on CPHC - FREE